SII conducting research to find monkeypox vaccine: CEO Adar Poonawalla

Poonawalla is learnt to have briefed Union Health Minister Mansukh Mandaviya on the subject during a meeting at the Nirman Bhawan here on Tuesday.

Adar Poonawalla, chief executive officer, Serum Institute of India
Adar Poonawalla, chief executive officer (CEO) of Serum Institute of India (Photo: PTI image)
Press Trust of India New Delhi
3 min read Last Updated : Aug 02 2022 | 7:02 PM IST

Serum Institute of India CEO Adar Poonawalla Tuesday said his firm is conducting research to find a vaccine against monkeypox as cases rise in the country.

Poonawalla is learnt to have briefed Union Health Minister Mansukh Mandaviya on the subject during a meeting at the Nirman Bhawan here on Tuesday.

India has so far reported eight cases of monkeypox, the latest a man from Delhi.

The Pune-based National Institute of Virology (NIV), which functions under the

Indian Council of Medical Research (ICMR), has already isolated monkeypox virus from the clinical specimen of a patient.

The ICMR on July 27 invited expression of interest (EOI) proposing to handover the virus strain to interested Indian vaccine manufacturers, pharma companies and in-vitro diagnostic (IVD) for developing an indigenous vaccine and diagnostic kits.

Meanwhile, a task force on monkeypox has been constituted to closely monitor the emerging situation in the country and decide on response initiatives.

The World Health Organisation (WHO) recently declared monkeypox a global public health emergency of international concern.

According to the WHO, monkeypox is a viral zoonosis -- a virus transmitted to humans from animals -- with symptoms similar to smallpox although clinically less severe.

Monkeypox typically manifests itself with fever, rash and swollen lymph nodes and may lead to a range of medical complications. It is usually a self-limited disease with symptoms lasting for two to four weeks.

The 'Guidelines on Management of Monkeypox Disease' issued by the Centre, stated that human-to-human transmission occurs primarily through large respiratory droplets generally requiring prolonged close contact.

It can also be transmitted through direct contact with body fluids or lesions, and indirect contact with lesion material such as through contaminated clothing or linen of an infected person. Animal-to-human transmission may occur by bite or scratch of infected animals or through bush meat preparation.

The incubation period is usually from six to 13 days and the case fatality rate of monkeypox has historically ranged up to 11 per cent in the general population and higher among children. In recent times, the case fatality rate has been around three to six per cent.

The symptoms include lesions which usually begin within one to three days from the onset of fever, lasting for around two to four weeks and are often described as painful until the healing phase when they become itchy. A notable predilection for palm and soles is characteristic of monkeypox, the guidelines stated.

(Only the headline and picture of this report may have been reworked by the Business Standard staff; the rest of the content is auto-generated from a syndicated feed.)

Subscribe to Business Standard digital and get complimentary access to The New York Times

Quarterly Starter

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

Save 46%

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Access to Exclusive Premium Stories Online

  • Over 30 behind the paywall stories daily, handpicked by our editors for subscribers

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

Topics :Serum Institute of IndiaVaccineMansukh Lal MandaviyaICMR

First Published: Aug 02 2022 | 7:02 PM IST

Next Story